An alternative marker of low-density lipoprotein cholesterol in coronary artery disease: non-high-density lipoprotein cholesterol

被引:3
|
作者
Ercan, Mujgan [1 ]
Oguz, Esra [1 ]
Yilmaz, Fatma Meric [2 ]
Bogdaycioglu, Nihal [1 ]
Unal, Kubranur [1 ]
Sahin, Deniz [3 ]
Uysal, Sema [1 ]
机构
[1] Ankara Numune Training & Res Hosp, Dept Clin Biochem, Ankara, Turkey
[2] Yildirim Beyazit Univ, Dept Biochem, Fac Med, Ankara, Turkey
[3] Ankara Numune Training & Res Hosp, Dept Cardiol, Ankara, Turkey
关键词
Non-high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; coronary artery disease; TREATMENT PANEL-III; HEART-DISEASE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; APOLIPOPROTEIN-B; STATIN TREATMENT; PARTICLE NUMBER; RISK-FACTORS; PREDICTION; MANAGEMENT;
D O I
10.3906/sag-1308-116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: Dyslipidemia is one of the most important risk factors for coronary artery disease (CAD), and low-density lipoprotein cholesterol (LDL-C) is used to measure dyslipidemia. Non-high-density lipoprotein cholesterol (non-HDL-C) seems to be an alternative parameter to LDL-C as it is not influenced by triglyceride (TG) levels. The aim of this study is to compare non-HDL-C and LDL-C levels as risk markers in CAD patients. Materials and methods: One hundred and ten CAD patients and 42 individuals with normal coronary angiography results were included in this study. Patients were divided into 2 groups: TG < 200 mg/dL (n = 75) as group 1 and TG > 200 mg/dL (n = 35) as group 2. Total cholesterol (TC), TG, and HDL-C levels were analyzed with a Roche Modular P800 autoanalyzer. LDL-C and non-HDL-C levels were calculated. Results: There were statistically significant differences in TC, TG, HDL-C, and non-HDL-C levels when the groups were compared. Non-HDL-C levels of group 2 were statistically higher than those of group 1 and the control group. There was no significant difference in LDL-C levels between the groups. Conclusion: Non-HDL-C levels are better risk markers than LDL-C levels, especially in patients with TG > 200 mg/dL, and non-HDL-C levels should be taken into consideration when evaluating the risk of CAD.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 50 条
  • [1] Discordance of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol with Severity of Coronary Artery Disease
    Castro, Iran
    Fontana Filho, Hugo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 114 (03) : 476 - 476
  • [2] Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?
    Sniderman, Allan
    McQueen, Matt
    Contois, John
    Williams, Ken
    Furberg, Curt D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (03) : 152 - 155
  • [3] Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement
    Contois, John H.
    Warnick, G. Russell
    Sniderman, Allan D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (04) : 264 - 272
  • [4] Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care
    Bilgic, Selin
    Sniderman, Allan D.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (01) : 49 - 53
  • [5] Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study
    Okamura, Tomonori
    Kokubo, Yoshihiro
    Watanabe, Makoto
    Higashiyama, Aya
    Miyamoto, Yoshihiro
    Yoshimasa, Yasunao
    Okayama, Akira
    ATHEROSCLEROSIS, 2009, 203 (02) : 587 - 592
  • [6] Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol
    Sniderman, Allan D.
    Islam, Shofiqul
    McQueen, Matthew
    Pencina, Michael
    Furberg, Curt D.
    Thanassoulis, George
    Yusuf, Salim
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (10):
  • [7] Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper
    Colivicchi, Furio
    Di Fusco, Stefania Angela
    Arca, Marcello
    Leggio, Massimo
    Caldarola, Pasquale
    Murrone, Adriano
    Valente, Serafina
    Urbinati, Stefano
    Roncon, Loris
    Amodeo, Vincenzo
    Aspromonte, Nadia
    Cipriani, Manlio
    Domenicucci, Stefano
    Francese, Giuseppina Maura
    Imazio, Massimo
    di Uccio, Fortunato Scotto
    Di Lenarda, Andrea
    Gulizia, Michele Massimo
    Gabrielli, Domenico
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (08) : 609 - 617
  • [8] Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese
    Gu, Xiaoying
    Yang, Xueli
    Li, Ying
    Cao, Jie
    Li, Jianxin
    Liu, Xiaoqing
    Chen, Jichun
    Shen, Chong
    Yu, Ling
    Huang, Jianfeng
    Gu, Dongfeng
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (07) : 1063 - 1070
  • [9] Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)
    Cao, Jing
    Nomura, Sarah O.
    Steffen, Brian T.
    Guan, Weihua
    Remaley, Alan T.
    Karger, Amy B.
    Ouyang, Pamela
    Michos, Erin D.
    Tsai, Michael Y.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (01) : 109 - +
  • [10] Discordance of apolipoprotein B with low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol and coronary atherosclerosis
    Su, Xin
    Cai, Xueli
    Pan, Yuesong
    Sun, Jingping
    Jing, Jing
    Wang, Mengxing
    Meng, Xia
    Wang, Yongjun
    Wei, Tiemin
    He, Yan
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (18) : 2349 - 2358